Esaote, a manufacturer of medical diagnostic systems headquartered in Genoa and Florence, Italy, unveiled a new portable ultrasound system to reduce cardiac examination time at the meeting of the European Association of Cardiovascular Imaging (EACVI) on May 10-12, 2023 in Barcelona.
MyLabTMOmega eXP features advanced cardio tools and AI-powered automation to deliver precise quantification and reduce elaboration time and overall examination time for cardiologists and mobile service professionals.
With the cardiovascular dedicated configuration, Esaote offers best-in-class diagnostic capability and high-level flexibility to cardiologists and mobile service professionals, according to Martina Cereseto, Global Product Manager at Esaote. ‘Advanced imaging processing tools, portability and connectivity are the strong points of this scanner, aimed at meeting the needs of tomorrow’s healthcare systems,’ she said. ‘Furthermore, the new generation of XCrystal transducers enables the acquisition of detailed images with high temporal and spatial resolution, thus enhancing diagnostic confidence in any clinical setting, from private echo-labs to hospitals, and from general cardiology departments to ICU, CCU, emergency rooms and Point-of-Care units.’
Esaote also showcased Suitestensa CVIS, an all-in-one cardiovascular management solution for enterprises, and Caas Qardia, an echocardiography software platform during the EACVI meeting. Both tools were developed by Ebit and Pie Medical Imaging (PMI), Esaote’s medical IT subsidiaries.
Encompassing all workflows, exams, images and post processing, the Suitestensa CVIS platform is a comprehensive patient-oriented approach to all cardiology specialties: cardiac catheterization, interventional cardiology, echocardiography, ECG, arrhythmology, general cardiology, and cardiovascular surgery. Complementing patient workflow management, the platform includes a complete telemedicine and remote monitoring module.
AI-driven workflows aimed at automating key clinical echocardiography measurements are one of the distinctive features of Caas Qardia, PMI’s new solution for myocardial strain analysis, stress-echo, diastolic function assessment, and (PISA) valve analysis.
PMI integrates its AI-driven ventricular volumetric and strain analysis into Esaote’s MyLab scanners to facilitate on-cart echocardiographic analysis.
At EACVI, PMI also showcased 4D Flow cardiac MRI analysis (Caas MR Solutions) and CT/3DTEE-based pre-procedural transcatheter planning (3mensio).
‘Artificial Intelligence, advanced quantification tools, enhanced connectivity for better data sharing and remote consultationare the key features that we are investing in for cardiovascular imaging, in order to provide clinicians with efficient and accurate analysis tools,’ the group wrote in a communiqué.
More information: www.esaote.com
